NuCana falls after wider Q4 loss

NuCana

05/04/2023 16:24

** Shares of UK-based clinical-stage biopharmaceutical co NuCana plc  NCNA.O  down about 1%
at 87 cents
    ** Loss widened in Q4 to 0.29 pound per share from a loss of 0.26 pound per share an year
earlier 
    ** Research and development expenses in Q4 grew to about 13.2 mln pounds from 10.6 mln
pounds an year earlier 
    ** As of Dec. 31, 2022, co had cash and cash equivalents of 41.9 mln pounds, down from 60.3
mln pounds at Dec. 31, 2021
    ** Anticipates cash runway into 2025
    ** YTD stock was up about 29.2%

 (Reporting by Vaibhav Sadhamta)
 ((Vaibhav.sadhamta@thomsonreuters.com))